Lenzilumab in Addition to Azacitidine Improves Complete Response Rates in Chronic Myelomonocytic Leukemia

Hiwase, D; Ross, DM; Lane, SW; Thompson-Peach, C; Fong, CY; Yong, ASM; Yeung, DT; Hughes, TP; Thomas, D

BLOOD, 2023; 142 ():